Pseudoprogression in a Patient with Metastatic Lung Adenocarcinoma Treated with Nivolumab
Arch Bronconeumol (Engl Ed). 2019 Mar;55(3):168-169.
doi: 10.1016/j.arbres.2018.06.005.
Epub 2018 Jul 14.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Cirugía Torácica, Hospital Universitario Ramón y Cajal, Madrid, España. Electronic address: [email protected].
- 2 Servicio de Radiodiagnóstico, Hospital Universitario Ramón y Cajal, Madrid, España.
- 3 Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, España.
- 4 Department of Adult Medicine, Institut de Cancérologie Gustave Roussy, París, Francia.
No abstract available
MeSH terms
-
Adenocarcinoma of Lung / drug therapy*
-
Adenocarcinoma of Lung / secondary*
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Disease Progression
-
Female
-
Humans
-
Middle Aged
-
Nivolumab / therapeutic use*
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab